CHOLESTYRAMINE PACKET

Cholestyramine
$0.6370per EA

Strength

4 g/8.3g

Manufacturer

TAGI Pharma Inc.

NDC

51224001120

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

7/17/2024

Active Ingredients

CHOLESTYRAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA209597

On Market Since

3/10/2021

Pharmacological Classes

Bile Acid Sequestrant
Bile-acid Binding Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-34.4%

5Y

N/A

All

-42.5%